(Headline USA) The Biden administration said Wednesday it will release doses of prescription flu medicine from the Strategic National Stockpile to states as flu-sickened patients continue to flock to hospitals and doctors’ offices around the country.
The decision to tap into the emergency medical reserves, like Biden’s earlier call to nearly deplete America’s emergency oil reserves, comes as the result of both poor policy and lack of planning.
Those have been the hallmark of a Biden presidency that has brought crises to the brink in everything from the immigration debate to the federal budget, and even the food supply.
While Biden’s administration colluded with Big Pharma to impose vaccine mandates related to COVID-19, which has now evolved into a far less threatening strain enabling natural immunity for many, it appears to have been ignoring the more commonplace threat of annual influenza strains.
Compounding the issue of shortages is the lingering vaccine hesitancy many feel in the wake of COVID mandates and reports that some of those who sought the annual flu shot had instead been given the COVID vaccine, either by mistake or design.
Whatever the underlying factors may be, this year’s flu season has hit hard and early, leaving bare shelves at pharmacies and grocery stores, and a run on over-the-counter medicines as cases have spiked. The Centers for Disease Control and Prevention estimates that the flu has resulted in 150,000 hospitalizations and 9,300 deaths so far this season.
Now, Biden is tapping into the national stockpile—a move reminiscent of the Obama administration’s decision to deplete the domestic supply of N95 facemasks during the a series of health crises and failing to replenish them in the leadup to COVID-19.
“Jurisdictions will be able to get the support they need to keep Americans healthy as flu cases rise this winter,” Dawn O’Connell, an assistant secretary for preparedness and response at the Health and Human Services Department, which oversees the CDC, said in a statement.
States will be able to request doses of the prescription flu medication Tamiflu kept in the Strategic National Stockpile from HHS. The administration is not releasing how many doses will be made available. Antiviral medications were released from the stockpile more than a decade ago during the H1N1, also known as swine flu, pandemic.
Last week, the federal agency also announced it would allow states to dip into statewide stockpiles for Tamiflu, making millions of treatment courses available. Tamiflu can be prescribed to treat flu in people over the age of 2 weeks old.
This flu season is coming on the heels of a nasty spike of RSV, or respiratory syncytial virus, cases in children and just as COVID-19 cases are climbing—again.
Spot shortages of over-the-counter pain relievers and medicines have been reported at stores around the country, particularly for children.
HHS Secretary Xavier Becerra and Food and Drug Administration Commissioner Robert Califf hosted conversations Tuesday with leaders representing pharmaceutical companies to discuss how manufacturers are working to keep in-demand remedies available.
The companies told the agencies that they are not seeing widespread shortages. Meanwhile, major drug makers like Johnson & Johnson and Perrigo report their production lines are running around the clock.
Pharmacies, however, are limiting purchases of certain medicines, the Associated Press reported Monday. CVS Health, for example, has placed a two-product limit on all children’s pain relief products bought through its pharmacies or online. Walgreens is limiting customers online to six purchases of children’s over-the-counter fever reducing products.
The FDA has not reported a shortage of Tamiflu. However, the federal agency says the prescription antibiotic amoxicillin is in short supply due to increased demand.
Adapted from reporting by the Associated Press
